CA (Z), CA ,(SA), Executive MBA (UCT), Business, International Relations and the Political Economy (LSE)
Appointed to the board in December 2020
CJ was a partner at Ernst & Young from 2008 to 2017 during which time she served as an audit partner and the strategic growth markets leader for Africa. In 2017 she joined Adcorp Holdings as the group CFO, leading the company’s balance sheet restructuring process and later served as interim CEO from October 2019 to May 2020. CJ joined Ascendis in December 2020.
B.Acc, B.Acc (Hon), CA(SA)
Joined the group in July 2018
Marnus has a strong and diverse background in private equity, management consulting and accounting. His career includes eight years with global management consulting firm McKinsey & Company where he gained exposure to several sectors and industries. He was previously a director of Coast2Coast Capital for two years, responsible for value creation.
Joined the group in 2009
Chris has over 26 years’ experience in an extensive range of Medical Devices with a vast amount of time spent in Interventional & Hemodynamic Areas. During this time, he worked for Adcock Ingram, B Braun and Brittan Healthcare where he successfully ran the business for the Marconi family before it was sold. During this period, he was involved in various Sales, Marketing and operational roles. Chris was a co-owner of the interventional business that was sold out of Brittan Healthcare. Chris was a shareholder in Surgical Innovations when this business was sold to Ascendis in 2014.
B Com (Hons Marketing), CM (SA)
Joined the group in 2017
Lee-Ann has over 15 years FMCG experience, including four years in the cosmetics industry. She was previously brand general manager for MAC Cosmetics, Estee Lauder, Aerin and Tom Ford. Lee-Ann spent 10 years at SAB focusing mainly on the premium beer portfolio.
